Huadong Medicine Co. Ltd. announced that at its Annual General Meeting of 2021 held on 01 June 2022, elected Zhu Feipeng, Ye Bo as non-independent directors, Gao Xiangdong, Wang Ruwei as independent directors and Bai Xinhua, Zhou Yanwu, Qin Yun, Dong Jiqin as non-employee supervisors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29 CNY | -3.04% | -7.05% | -30.05% |
06-06 | Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic | RE |
06-06 | Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.05% | 7.21B | |
+30.30% | 78.37B | |
+3.54% | 25.35B | |
+8.31% | 8.85B | |
+13.45% | 8.85B | |
+17.70% | 5.33B | |
+1.92% | 4.15B | |
-7.07% | 3.47B | |
+9.54% | 3.32B | |
+1.68% | 3.08B |
- Stock Market
- Equities
- 000963 Stock
- News Huadong Medicine Co., Ltd
- Huadong Medicine Co., Ltd Approves Board Appointments